Non-Pharmacological Management of Hypertension
Non-Pharmacological Management of Hypertension NP assignment help Support the post in the following conversation. Focus on their perspective, ask appropriate questions, and add to the responses with information from other sources. Don't be subjective.It is critical to back up your claims using APA-formatted citations from both course materials and outside sources.YS Debate:Week 9 DebateManagement of Hypertension Without DrugsWho will gain from this evidence? Notably, hypertension management has been a concern in various parts of the world. The reception of non-pharmacological management of hypertension evidence will play a significant part in ensuring that the problem is handled. Health care organizations will benefit from the evidence collected and analyzed in this study, as stated by Kario et al. (2020). Notably, health care organizations have been working hard to develop a remedy and other approaches to help individuals overcome hypertension without increasing medical costs. The findings of this study will help medical professionals in various health care institutions provide reliable treatment strategies to hypertensive patients.It is important to mention that it will also help leaders and executives in health care businesses make educated strategic planning decisions. For example, the will focus on creating alternative techniques for educating hypertension patients about non-medication therapy. The funding will be used for other activities or programs outside purchasing hypertension drugs. Second, people with hypertension will be able to manage their illness without incurring large costs. They will learn about various diets and items that can help them maintain normal blood pressure. Again, doctors will educate patients on some physical exercises they can do to lower their blood pressure. This will help people with hypertension and those at risk of getting it (Kario et al., 2020s).Where will this evidence be most useful? According to Kario et al. (2020), primary care physicians frequently see patients first. In this scenario, the evidence will most likely effect primary care practitioners. When a patient has many symptoms of an illness or health issue, they go to their primary care provider first. Notably, the evidence will help primary care doctors help most hypertensive patients. This implies primary care doctors can build successful treatment programs to keep hypertension patients healthy. This indicates that the target audience for evidence distribution will be doctors who work in primary care organizations. Notably, they include nurse practitioners and physicians. Primary care nurses and physicians will be able to work together to combat hypertension.What is required? Several resources will be necessary for evidence distribution. One of them is a meeting room where the researcher will present the evidence. The room should be large enough to accommodate the maximum number of attendees. Second, I need a projector. In this situation, the projector will project the evidence on the wall. Third, I will need booklets to summarize the findings and distribute to the guests. Also, I will need someone to help me demonstrate some of the physical exercises that are useful in treating hypertension. The person will be a gym trainer who will help doctors comprehend various physical workouts for treating hypertension patients. I'll also need examples of some healthful foods. Mentioning or naming them will not suffice. As a researcher, I will need to explain these foods and diets to medical professionals.Who is the target audience? As indicated previously, primary care physicians will gain the most. In this situation, primary care physicians are the target audience. They include doctors, nurses, and other medical specialists who provide primary care to patients.What does this proof mean to your target audience? Informed leaders and other medical practitioners can make trustworthy and effective judgments in primary care settings. They will learn about non-pharmacological hypertension therapy. As explained by Kario et al. (2020), currently, health care organizations have ensured that they get supplies of different medications, which can be used to offer treatment to patients who suffer from hypertension. However, in this case, it is imperative to note that they will be able to revise their budgets and reduce the amount of finances, which is used to purchase medications for hypertension. In addition, the primary care providers will also benefit by achieving positive results in patient outcomes. This is because the evidence in this research has been proved that some of the techniques that can be employed to manage hypertension are effective. By applying this evidence, the primary care providers will have reduced operational budgets and this will ensure that they grow and develop.What are the risks of not distributing this evidence? One of the main potential risks of failing to disseminate the evidence on non-pharmacological management of hypertension will lead to health care organizations incurring increased expenses as they operate. This is because these organizations will have to ensure that they have all the medications, which are required for the treatment of hypertension. Secondly, the organizations may continue experiencing negative patient outcomes as they operate. This is because of the increased cases of hypertension among the population and the reduced medical practitioners. It is imperative to note that with reduced patients, the number of medical practitioners who work in health care organizations can be able to meet the demand of health and health care services. However, increased cases of hypertension will make it hard for these organizations to operate effectively.What are the barriers to dissemination of evidence? One of the main barriers is failing to have the required resources for the dissemination of the evidence. In this case, the researcher is supposed to be equipped with all the resources, which he or she requires to disseminate the evidence. Secondly, there is the issue of uncooperative audience or medical practitioners. The medical practitioners who will take part during the dissemination of evidence should ensure that they cooperate. For example, they should ensure that they ask questions on areas where they do not understand during the dissemination. Again, they can also raise queries on some of the challenges, which they may experience during the implementation of the evidence.The mode of dissemination to be applied in this case is PowerPoint presentation. It is imperative to note that a PowerPoint presentation has different features which allow the research to divide his work and topics in a manner that can be easily understood by the audience.ReferencesKario, K., Chia, Y. C., Sukonthasarn, A., Turana, Y., Shin, J., Chen, C. H., ... & Wang, J. G. (2020). Diversity of and initiatives for hypertension management in Asia—Why we need the HOPE Asia Network. The Journal of Clinical Hypertension, 22(3), 331-343.